Stay updated on CIN-107 Study in Uncontrolled Hypertension Clinical Trial
Sign up to get notified when there's something new on the CIN-107 Study in Uncontrolled Hypertension Clinical Trial page.

Latest updates to the CIN-107 Study in Uncontrolled Hypertension Clinical Trial page
- Check6 days agoNo Change Detected
- Check12 days agoChange DetectedThe study record for the Phase 2 baxdrostat (CIN-107) hypertension trial is displayed, including its eligibility criteria, study locations, treatment arms, outcome measures, and study documents.SummaryDifference73%

- Check20 days agoChange DetectedThe site footer revision label changes from v3.7.2 to v3.8.0 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check27 days agoChange DetectedA site-wide banner announces NIH’s transition from using “Artificial Intelligence” to “Super Intelligence” terminology.SummaryDifference1%

- Check34 days agoChange DetectedThe ClinicalTrials.gov footer now shows revision v3.7.2 instead of v3.7.1.SummaryDifference0.2%

- Check41 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 Forbidden page.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page now displays a 403 Forbidden error instead of the study record, indicating an access or loading issue. The error replaces the visible study details and navigation that were present on the previous page.SummaryDifference18%

Stay in the know with updates to CIN-107 Study in Uncontrolled Hypertension Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CIN-107 Study in Uncontrolled Hypertension Clinical Trial page.